GlassScriptStelkast Generic Hip Instruments
Payments companies reported to CMS as associated with Stelkast Generic Hip Instruments. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Stelkast Generic Hip Instruments, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Stelkast Generic Hip Instruments
These are the largest totals companies reported as associated with Stelkast Generic Hip Instruments. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Gustavel | Boise, ID | Sports Medicine (Orthopaedic Surgery) | $175.39 |
| Paul Montalbano | Boise, ID | Neurological Surgery | $175.39 |
| Michael Daines | Caldwell, ID | Orthopaedic Surgery | $175.39 |
| James Carson | Houston, TX | Orthopaedic Surgery | $160.92 |
| Dustin Hambright | Mount Pleasant, SC | Adult Reconstructive Orthopaedic Surgery | $156.00 |
| Peter Lementowski | Valhalla, NY | Adult Reconstructive Orthopaedic Surgery | $128.95 |
| Keith Reinhardt | Bay Shore, NY | Orthopaedic Surgery | $125.43 |
| Gustavo Godoy | New Orleans, LA | Orthopaedic Surgery | $43.53 |
| Adam Ross | Scottsdale, AZ | Orthopaedic Surgery | $17.85 |
| Sam Yee Wu | New York, NY | Adult Health (Nurse Practitioner) | $15.22 |
Share this page
The CSV has this whole record: yearly totals, every maker, the specialty mix, and the clinicians with the largest associated totals.
Prescribed Stelkast Generic Hip Instruments?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.